Acquisition enhances scale and will create platform for sustainable long-term growth Expected to be accretive in 2016 and very strongly accretive thereafter London, 28 July 2015 – Hikma Pharmaceuticals PLC (“Hikma” or the “Company”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces that it […]